BNTC - Benitec Biopharma Inc.

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 8.43

Open

$ 8.13

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 8.11 - $ 8.32

52 Week Range

$ 1.86 - $ 10.29

Volume

17,261

Average Volume

Market Cap

22.06M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-13-2024	03-31-2024	10-Q
2	02-13-2024	12-31-2023	10-Q
3	11-13-2023	09-30-2023	10-Q
4	09-21-2023	06-30-2023	10-K
5	05-15-2023	03-31-2023	10-Q
6	02-13-2023	12-31-2022	10-Q
7	11-10-2022	09-30-2022	10-Q
8	09-02-2022	06-30-2022	10-K
9	05-16-2022	03-31-2022	10-Q
10	02-14-2022	12-31-2021	10-Q
11	11-15-2021	09-30-2021	10-Q
12	09-20-2021	06-30-2021	10-K
13	05-12-2021	03-31-2021	10-Q
14	02-09-2021	12-31-2020	10-Q
15	11-13-2020	09-30-2020	10-Q
16	09-23-2020	06-30-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
05/13/2024 16:31:04

Benitec Biopharma Q3 2024 Revenue $0 Down ...
05/13/2024 12:19:12

Revenue $0 Down From

Benitec Biopharma Q3 2024 GAAP EPS $(1.64)...
05/13/2024 12:18:48

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(1.64) per share which missed the analyst consensus estimate of $...

Benitec Biopharma 13G Filing Shows Steven ...
04/29/2024 15:48:49

- SEC Filing

JMP Securities Maintains Market Outperform...
04/22/2024 16:17:56

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

why-is-gene-therapy-developer-benitec-biopharma-stock-trading-higher-on-thursday

Why Is Gene Therapy Developer Benitec Biop...
04/18/2024 17:04:45

Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces inte...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

Benitec Biopharma Shares Halted On Circuit...
04/18/2024 13:39:57

Market-Moving News for April 18th
04/18/2024 12:35:31

BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

Benitec Biopharma Reports Interim Clinical...
04/18/2024 11:32:18

Benitec Biopharma Reports Oversubscribed P...
04/18/2024 11:12:29

Benitec Biopharma announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5.749 million...

12 Health Care Stocks Moving In Monday's I...
03/04/2024 17:34:40

Benitec Biopharma Files For Mixed Shelf Of...
02/23/2024 21:14:56

-SEC Filing

JMP Securities Maintains Market Outperform...
02/15/2024 18:58:07

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

Benitec Biopharma Q2 EPS $(2.64) Up From $...
02/13/2024 13:06:12

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.64) per share. This is a 20.96 percent increase over losses of...

JMP Securities Maintains Market Outperform...
01/24/2024 17:14:51

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

Benitec Biopharma Has Dosed The First Subj...
11/30/2023 12:02:22

Benitec Biopharma Q1 EPS $(2.76) Up From $...
11/13/2023 13:23:51

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.76) per share. This is a 65.46 percent increase over losses of...